Bruker Corporation

62.55-1.28-2.01%Vol 1.19M1Y Perf -15.75%
Jun 28th, 2022 16:00 DELAYED
BID58.51 ASK67.01
Open64.09 Previous Close63.83
Pre-Market- After-Market62.55
 - -  - -%
Target Price
80.71 
Analyst Rating
Moderate Buy 2.00
Potential %
29.03 
Finscreener Ranking
★+     43.49
Insiders Trans % 3/6/12 mo.
100/-60/-82 
Value Ranking
     39.97
Insiders Value % 3/6/12 mo.
100/-97/-100 
Growth Ranking
★★★★     59.82
Insiders Shares Cnt. % 3/6/12 mo.
100/-97/-99 
Income Ranking
+     28.64
Price Range Ratio 52W %
18.47 
Earnings Rating
Neutral
Market Cap9.34B 
Earnings Date
1st Aug 2022
Alpha0.01 Standard Deviation0.09
Beta1.25 

Today's Price Range

62.3765.04

52W Range

55.8092.35

5 Year PE Ratio Range

22.3089.70

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
5.10%
1 Month
-0.56%
3 Months
-2.21%
6 Months
-22.23%
1 Year
-15.75%
3 Years
27.79%
5 Years
119.57%
10 Years
389.87%

TickerPriceChg.Chg.%
BRKR62.55-1.2800-2.01
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
1.50
2.60
0.54
1.20
29.90
Leverage Ratio 3.20
ProfitabilityValueIndustryS&P 500US Markets
50.20
17.10
20.70
14.40
11.58
RevenueValueIndustryS&P 500US Markets
2.46B
16.47
6.74
7.16
DividendsValueIndustryS&P 500US Markets
0.31
0.20
0.59
0.26
Payout ratio12.00
Earnings HistoryEstimateReportedSurprise %
Q01 20220.410.4919.51
Q04 20210.590.590.00
Q03 20210.450.6340.00
Q02 20210.400.4410.00
Q01 20210.320.4437.50
Q04 20200.570.581.75
Q03 20200.330.4227.27
Q02 20200.050.21320.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.45-4.26Negative
9/2022 QR0.60-4.76Negative
12/2022 FY2.310.00-
12/2023 FY2.611.16Positive
Next Report Date1st Aug 2022
Estimated EPS Next Report0.45
Estimates Count5
EPS Growth Next 5 Years %18.80
Volume Overview
Volume1.19M
Shares Outstanding149.26K
Shares Float72.31M
Trades Count15.49K
Dollar Volume75.33M
Avg. Volume802.64K
Avg. Weekly Volume917.80K
Avg. Monthly Volume732.40K
Avg. Quarterly Volume757.71K

Bruker Corporation (NASDAQ: BRKR) stock closed at 63.83 per share at the end of the most recent trading day (a -0.55% change compared to the prior day closing price) with a volume of 797.45K shares and market capitalization of 9.34B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7230 people. Bruker Corporation CEO is Frank H. Laukien.

The one-year performance of Bruker Corporation stock is -15.75%, while year-to-date (YTD) performance is -23.93%. BRKR stock has a five-year performance of 119.57%. Its 52-week range is between 55.8 and 92.35, which gives BRKR stock a 52-week price range ratio of 18.47%

Bruker Corporation currently has a PE ratio of 34.70, a price-to-book (PB) ratio of 9.42, a price-to-sale (PS) ratio of 3.88, a price to cashflow ratio of 37.30, a PEG ratio of 2.32, a ROA of 8.79%, a ROC of 14.01% and a ROE of 29.21%. The company’s profit margin is 11.58%, its EBITDA margin is 20.70%, and its revenue ttm is $2.46 Billion , which makes it $16.47 revenue per share.

Of the last four earnings reports from Bruker Corporation, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Bruker Corporation’s next earnings report date is 01st Aug 2022.

The consensus rating of Wall Street analysts for Bruker Corporation is Moderate Buy (2), with a target price of $80.71, which is +29.03% compared to the current price. The earnings rating for Bruker Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bruker Corporation has a dividend yield of 0.31% with a dividend per share of $0.20 and a payout ratio of 12.00%.

Bruker Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 14.36, ATR14 : 2.25, CCI20 : 70.57, Chaikin Money Flow : -0.08, MACD : 0.45, Money Flow Index : 68.05, ROC : -0.78, RSI : 56.11, STOCH (14,3) : 73.40, STOCH RSI : 0.79, UO : 50.90, Williams %R : -26.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bruker Corporation in the last 12-months were: Burkhard Prause (Option Excercise at a value of $327 505), Burkhard Prause (Sold 10 446 shares of value $873 875 ), Frank H. Laukien (Buy at a value of $98 559), Frank H. Laukien (Option Excercise at a value of $11 333 990), Frank H. Laukien (Sold 249 168 shares of value $19 243 632 ), Juergen Srega (Option Excercise at a value of $3 774 107), Juergen Srega (Sold 202 216 shares of value $18 106 360 ), Marc A. Kastner (Option Excercise at a value of $199 000), Marc A. Kastner (Sold 10 000 shares of value $768 600 ), Mark Munch (Option Excercise at a value of $420 382), Mark Munch (Sold 21 210 shares of value $1 685 647 ), William A. Linton (Option Excercise at a value of $76 620)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
4 (57.14 %)
4 (57.14 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
3 (42.86 %)
3 (42.86 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
1.86
Moderate Buy
1.86

Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.

CEO: Frank H. Laukien

Telephone: +1 978 663-3660

Address: 40 Manning Road, Billerica 01821, MA, US

Number of employees: 7 230

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

TipRanks News for BRKR

Thu, 16 Jun 2022 12:45 GMT Analysts Offer Insights on Healthcare Companies: Bruker (BRKR) and Gracell Biotechnologies (GRCL)

- TipRanks. All rights reserved.

Mon, 09 May 2022 02:19 GMT Bruker (BRKR) Gets a Hold Rating from Stifel Nicolaus

- TipRanks. All rights reserved.

Thu, 07 Apr 2022 13:36 GMT Bruker Acquires IonSense in DART-MS Push

- TipRanks. All rights reserved.

Tue, 15 Feb 2022 14:35 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: AstraZeneca (AZN), Bruker (BRKR) and Neurocrine (NBIX)

- TipRanks. All rights reserved.

Mon, 14 Feb 2022 13:46 GMT Analysts Offer Insights on Healthcare Companies: Bruker (BRKR) and NeuBase Therapeutics (NBSE)

- TipRanks. All rights reserved.

Tue, 11 Jan 2022 15:23 GMT Bruker (BRKR) Gets a Buy Rating from Leerink Partners

- TipRanks. All rights reserved.

News

Stocktwits